Botanical species · safety record

Filipendula ulmaria

The EFSA Compendium of Botanicals holds 26 constituent measurements for Filipendula ulmaria. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Filipendula ulmaria (L.) Maxim.

26Constituent measurements
0Safety records
7Cited sources
102Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 102 licensed products naming Filipendula ulmaria as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh
  • solid

Source material stated

  • Aerial parts
  • Dried flower(s)
  • Filipendula ulmaria
  • Filipendula ulmaria - Herb top
  • Filipendula ulmaria - leaf
  • Flower
  • Flower tops
  • Flowering grass

What the records describe

Constituents measured

  • Methyl salicylate6
  • Salicylaldehyde6
  • Tannins5
  • Saponins4
  • Salicylic acid3
  • Ellagitannins (hydrolysable tannins)1
  • P-coumaric acid1

Plant parts

  • Flower12
  • Aerial part of plants6
  • Leaves6
  • Stem2
  • stalk2

Preparations

  • Solvent extraction14
  • Essential oil12

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Methyl salicylateAerial part of plantsEssential oil4.6 Percent AreaGC-MSResolve DOI
Methyl salicylateFlowerEssential oil≤ 23.9 Percent AreaGC-MSResolve DOI
Methyl salicylateLeavesEssential oil39.1 Percent AreaGC-MSResolve DOI
Methyl salicylateStem / stalkEssential oil81.9 Percent AreaGC-MSResolve DOI
SalicylaldehydeFlowerEssential oil≤ 7.3 Percent AreaGC-MSResolve DOI
SalicylaldehydeLeavesEssential oil6.3 Percent AreaGC-MSResolve DOI
SalicylaldehydeStem / stalkEssential oil16.9 Percent AreaGC-MSResolve DOI
SalicylaldehydeAerial part of plantsEssential oil67.5 Percent AreaGC-MSResolve DOI
Salicylic acidAerial part of plantsSolvent extraction≥ 0.39 Milligram/gramHPLC-DADResolve DOI
Salicylic acidAerial part of plantsSolvent extraction≤ 0.46 Milligram/gramHPLC-DADResolve DOI
Ellagitannins (hydrolysable tannins)FlowerSolvent extractionHPLC with standard detection methodsNo resolvable identifier
Methyl salicylateFlowerEssential oil≥ 11.2 Percent AreaGC-MSNo resolvable identifier
Methyl salicylateFlowerEssential oil≤ 28.2 Percent AreaGC-MSNo resolvable identifier
P-coumaric acidAerial part of plantsSolvent extraction31 Microgram/gramUHPLC-MS-MSNo resolvable identifier
SalicylaldehydeFlowerEssential oil≥ 2.8 Percent AreaGC-MSNo resolvable identifier
SalicylaldehydeFlowerEssential oil≤ 12.4 Percent AreaGC-MSNo resolvable identifier
Salicylic acidAerial part of plantsSolvent extraction630 Microgram/gramUHPLC-MS-MSNo resolvable identifier
SaponinsLeavesSolvent extraction≤ 14.6 PercentGravimetric testsNo resolvable identifier
SaponinsLeavesSolvent extraction≥ 0.6 PercentGravimetric testsNo resolvable identifier
SaponinsFlowerSolvent extraction≥ 4 PercentGravimetric testsNo resolvable identifier
SaponinsFlowerSolvent extraction≤ 30.7 PercentGravimetric testsNo resolvable identifier
TanninsFlowerSolvent extraction≥ 38.3 PercentVolumetric testsNo resolvable identifier
TanninsLeavesSolvent extraction≤ 28.1 PercentVolumetric testsNo resolvable identifier
TanninsFlowerSolvent extraction≤ 56.8 PercentVolumetric testsNo resolvable identifier
TanninsLeavesSolvent extraction≥ 19.4 PercentVolumetric testsNo resolvable identifier
TanninsFlowerSolvent extraction12.5 PercentUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Vysochina, G. I., Kukushkina, T. A., Shaldaeva, T. M. The content of the main groups of biologically active substances in plants of the Siberian species of Filipendula mill.. Khimiya rastitel'nogo syr'ya, 2014, p. 129-135.
  2. Papp, Ildiko., Simandi, Bela., Blazics, Balazs., Alberti, Agnes., Hethelyi, Eva., Szoke, Eva., Kery, Agnes. Monitoring Volatile and Non-Volatile Salicylates in Filipendula ulmaria by Different Chromatographic Techniques. CHROMATOGRAPHIA, 2008, vol. 68, p. S125-S129. DOI
  3. Moilanen, Johanna., Sinkkonen, Jari., Salminen, Juha-Pekka. Characterization of bioactive plant ellagitannins by chromatographic, spectroscopic and mass spectrometric methods. Chemoecology, 2013, p. 165-179.
  4. Barnaulov, O. D., Kumkov, A. V., Khalikova, N. A., Kozhina, I. S., Shukhobodskii, B. A. Chemical composition and primary evaluation of the properties of preparations from Filipendula ulmaria (L.) Maxim flowers. Rastitel'nye resursy, 1977, p. 661-669.
  5. Zykova, I. D., Efremov, A. A. Componental compound of essential oil from inflorescences of Filipendula ulmaria (L) Maxim in during stages of flovering and fruting. Khimiya rastitel'nogo syr'ya, 2011, p. 133-136.
  6. Bijttebier, Sebastiaan., Van der Auwera, Anastasia., Voorspoels, Stefan., Noten, Bart., Hermans, Nina., Pieters, Luc., Apers, Sandra. A First Step in the Quest for the Active Constituents in Filipendula ulmaria (Meadowsweet): Comprehensive Phytochemical Identification by Liquid Chromatography Coupled to Quadrupole-Orbitrap Mass Spectrometry. Planta medica, 2016.
  7. Harbourne, Niamh., Jacquier, Jean Christophe., O'Riordan, Dolores. Optimisation of the aqueous extraction conditions of phenols from meadowsweet (Filipendula ulmaria L.) for incorporation into beverages . Food chemistry, 2009, vol. 116, no. 3, p. 722-727. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue